Literature DB >> 10732642

Immunology, microbiology, and the recalcitrant wound.

P D Thomson1.   

Abstract

Wounding of normal skin initiates an acute inflammatory response that ordinarily contributes to the healing process. The underlying process is orchestrated by the specific and nonspecific immune response. Inflammatory cells provide growth factors and stimulate the deposition of matrix proteins and phagocytose debris. However, the maturation and resolution of a wound may be complicated by micro-organisms. The effects of micro-organisms on oxygen consumption and pH, or toxin production, may interrupt the natural course of wound healing. Thus, a wound may not progress from the acute phase and heal, but may become a nonhealing chronic or recalcitrant wound as long as the antigens from micro-organisms or underlying pathology remain. Depending on the underlying disease pathology and the micro-organism's virulence, microbial growth in acute or chronic wounds may lead to invasive wound infection. Wound infection is a complex interaction involving the host as well as the numbers and types of micro-organisms present. The literature suggests that micro-organisms alter the course of acute wound healing, and a body of evidence exists that suggests that large numbers of organisms in chronic wounds delay the healing process. However, other evidence suggests that, despite bacteria, most chronic wounds progress toward healing, depending upon the wound care strategy employed. Current therapy seeks to alter the relationships between microbial colonization and host defenses by providing an environment that tips the balance in favor of healing. The role of bacteria in acute and chronic wounds may span the spectrum from initiation of inflammation and the healing process, to colonization, invasive infection, systemic sepsis, organ system failure, and death. Understanding the interaction of the wound, wound micro-organisms, and the immune response is central to understanding how best to develop therapeutic approaches.

Entities:  

Mesh:

Year:  2000        PMID: 10732642

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  7 in total

1.  Biofilms and delayed healing - an in vitro evaluation of silver- and iodine-containing dressings and their effect on bacterial and human cells.

Authors:  Katie A Bourdillon; Craig P Delury; Breda M Cullen
Journal:  Int Wound J       Date:  2017-05-14       Impact factor: 3.315

2.  Efficacy and safety of neutral pH superoxidised solution in severe diabetic foot infections.

Authors:  Fermín R Martínez-De Jesús; Antonio Ramos-De la Medina; José María Remes-Troche; David G Armstrong; Stephanie C Wu; Jose Luis Lázaro Martínez; Juan V Beneit-Montesinos
Journal:  Int Wound J       Date:  2007-10-22       Impact factor: 3.315

3.  Polyhexanide 0.2% in treatment of trophic foot ulcers in leprosy - preliminary study.

Authors:  Túlio Neutzling Zanchin; Cássio Battisti Serafini; Francine Silva Brandão; José Augusto da Costa Nery
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

4.  High‑throughput sequencing analyses of oral microbial diversity in healthy people and patients with dental caries and periodontal disease.

Authors:  Tingtao Chen; Yan Shi; Xiaolei Wang; Xin Wang; Fanjing Meng; Shaoguo Yang; Jian Yang; Hongbo Xin
Journal:  Mol Med Rep       Date:  2017-05-17       Impact factor: 2.952

5.  Comparative analysis of single-species and polybacterial wound biofilms using a quantitative, in vivo, rabbit ear model.

Authors:  Akhil K Seth; Matthew R Geringer; Seok J Hong; Kai P Leung; Robert D Galiano; Thomas A Mustoe
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

6.  Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing.

Authors:  Scot E Dowd; Yan Sun; Patrick R Secor; Daniel D Rhoads; Benjamin M Wolcott; Garth A James; Randall D Wolcott
Journal:  BMC Microbiol       Date:  2008-03-06       Impact factor: 3.605

7.  Leprosy ulcers in a rural hospital of Ethiopia: pattern of aerobic bacterial isolates and drug sensitivities.

Authors:  José M Ramos; Ramón Pérez-Tanoira; Cristina García-García; Laura Prieto-Pérez; María C Bellón; Fernando Mateos; Gabre Tisisano; Tafese Yohannes; Francisco Reyes; Miguel Górgolas
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-09-17       Impact factor: 3.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.